JAK Inhibitors for ET and PV: What have we learned so far? - 100004

Spotlight
Video

JAK Inhibitors for ET and PV: What have we learned so far?

imedex has 1207 videos Subscribe Here

Loading........
Description: In this presentation from the 2016 "European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes", Dr. Gunnar Birgegård discusses what we have learned so far regarding the use of JAK inhibitors in the treatment of essential thrombocythemia (ET) and polycythemia vera (PV).

A continuing education program related to this video is offered at the following location:
http://elc.imedex.com/ELC/A...

© 2016 Imedex, LLC.
Shared By : imedex
Posted on : 05/22/16
Added : 2 years ago



Recommended

Nothing found.